Skip to main content
Medicine LibreTexts

39.1: Appendix B- Major Fluid and Electrolyte Imbalances

  • Page ID
    111740
  • \( \newcommand{\vecs}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \)

    \( \newcommand{\vecd}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash {#1}}} \)

    \( \newcommand{\dsum}{\displaystyle\sum\limits} \)

    \( \newcommand{\dint}{\displaystyle\int\limits} \)

    \( \newcommand{\dlim}{\displaystyle\lim\limits} \)

    \( \newcommand{\id}{\mathrm{id}}\) \( \newcommand{\Span}{\mathrm{span}}\)

    ( \newcommand{\kernel}{\mathrm{null}\,}\) \( \newcommand{\range}{\mathrm{range}\,}\)

    \( \newcommand{\RealPart}{\mathrm{Re}}\) \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\)

    \( \newcommand{\Argument}{\mathrm{Arg}}\) \( \newcommand{\norm}[1]{\| #1 \|}\)

    \( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\)

    \( \newcommand{\Span}{\mathrm{span}}\)

    \( \newcommand{\id}{\mathrm{id}}\)

    \( \newcommand{\Span}{\mathrm{span}}\)

    \( \newcommand{\kernel}{\mathrm{null}\,}\)

    \( \newcommand{\range}{\mathrm{range}\,}\)

    \( \newcommand{\RealPart}{\mathrm{Re}}\)

    \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\)

    \( \newcommand{\Argument}{\mathrm{Arg}}\)

    \( \newcommand{\norm}[1]{\| #1 \|}\)

    \( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\)

    \( \newcommand{\Span}{\mathrm{span}}\) \( \newcommand{\AA}{\unicode[.8,0]{x212B}}\)

    \( \newcommand{\vectorA}[1]{\vec{#1}}      % arrow\)

    \( \newcommand{\vectorAt}[1]{\vec{\text{#1}}}      % arrow\)

    \( \newcommand{\vectorB}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \)

    \( \newcommand{\vectorC}[1]{\textbf{#1}} \)

    \( \newcommand{\vectorD}[1]{\overrightarrow{#1}} \)

    \( \newcommand{\vectorDt}[1]{\overrightarrow{\text{#1}}} \)

    \( \newcommand{\vectE}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash{\mathbf {#1}}}} \)

    \( \newcommand{\vecs}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \)

    \(\newcommand{\longvect}{\overrightarrow}\)

    \( \newcommand{\vecd}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash {#1}}} \)

    \(\newcommand{\ket}[1]{\left| #1 \right>}\)
    \(\newcommand{\bra}[1]{\left< #1 \right|}\)
    \(\newcommand{\braket}[2]{\left< #1 \vphantom{#2} \right| \left. #2 \vphantom{#1} \right>}\)
    \(\newcommand{\braopket}[3]{\left< #1 \vphantom{#2}\vphantom{#3} \right| #2 \vphantom{#1}\vphantom{#3} \left| #3 \vphantom{#1}\vphantom{#2} \right>}\)
    \(\newcommand{\qmvec}[1]{\mathbf{\vec{#1}}}\)
    \(\newcommand{\op}[1]{\hat{\mathbf{#1}}}\)
    \(\newcommand{\expect}[1]{\langle #1 \rangle}\)
    \(\newcommand{\dfn}[1]{\emph{\textbf{#1}}}\)

    \(\newcommand{\avec}{\mathbf a}\) \(\newcommand{\bvec}{\mathbf b}\) \(\newcommand{\cvec}{\mathbf c}\) \(\newcommand{\dvec}{\mathbf d}\) \(\newcommand{\dtil}{\widetilde{\mathbf d}}\) \(\newcommand{\evec}{\mathbf e}\) \(\newcommand{\fvec}{\mathbf f}\) \(\newcommand{\nvec}{\mathbf n}\) \(\newcommand{\pvec}{\mathbf p}\) \(\newcommand{\qvec}{\mathbf q}\) \(\newcommand{\svec}{\mathbf s}\) \(\newcommand{\tvec}{\mathbf t}\) \(\newcommand{\uvec}{\mathbf u}\) \(\newcommand{\vvec}{\mathbf v}\) \(\newcommand{\wvec}{\mathbf w}\) \(\newcommand{\xvec}{\mathbf x}\) \(\newcommand{\yvec}{\mathbf y}\) \(\newcommand{\zvec}{\mathbf z}\) \(\newcommand{\rvec}{\mathbf r}\) \(\newcommand{\mvec}{\mathbf m}\) \(\newcommand{\zerovec}{\mathbf 0}\) \(\newcommand{\onevec}{\mathbf 1}\) \(\newcommand{\real}{\mathbb R}\) \(\newcommand{\twovec}[2]{\left[\begin{array}{r}#1 \\ #2 \end{array}\right]}\) \(\newcommand{\ctwovec}[2]{\left[\begin{array}{c}#1 \\ #2 \end{array}\right]}\) \(\newcommand{\threevec}[3]{\left[\begin{array}{r}#1 \\ #2 \\ #3 \end{array}\right]}\) \(\newcommand{\cthreevec}[3]{\left[\begin{array}{c}#1 \\ #2 \\ #3 \end{array}\right]}\) \(\newcommand{\fourvec}[4]{\left[\begin{array}{r}#1 \\ #2 \\ #3 \\ #4 \end{array}\right]}\) \(\newcommand{\cfourvec}[4]{\left[\begin{array}{c}#1 \\ #2 \\ #3 \\ #4 \end{array}\right]}\) \(\newcommand{\fivevec}[5]{\left[\begin{array}{r}#1 \\ #2 \\ #3 \\ #4 \\ #5 \\ \end{array}\right]}\) \(\newcommand{\cfivevec}[5]{\left[\begin{array}{c}#1 \\ #2 \\ #3 \\ #4 \\ #5 \\ \end{array}\right]}\) \(\newcommand{\mattwo}[4]{\left[\begin{array}{rr}#1 \amp #2 \\ #3 \amp #4 \\ \end{array}\right]}\) \(\newcommand{\laspan}[1]{\text{Span}\{#1\}}\) \(\newcommand{\bcal}{\cal B}\) \(\newcommand{\ccal}{\cal C}\) \(\newcommand{\scal}{\cal S}\) \(\newcommand{\wcal}{\cal W}\) \(\newcommand{\ecal}{\cal E}\) \(\newcommand{\coords}[2]{\left\{#1\right\}_{#2}}\) \(\newcommand{\gray}[1]{\color{gray}{#1}}\) \(\newcommand{\lgray}[1]{\color{lightgray}{#1}}\) \(\newcommand{\rank}{\operatorname{rank}}\) \(\newcommand{\row}{\text{Row}}\) \(\newcommand{\col}{\text{Col}}\) \(\renewcommand{\row}{\text{Row}}\) \(\newcommand{\nul}{\text{Nul}}\) \(\newcommand{\var}{\text{Var}}\) \(\newcommand{\corr}{\text{corr}}\) \(\newcommand{\len}[1]{\left|#1\right|}\) \(\newcommand{\bbar}{\overline{\bvec}}\) \(\newcommand{\bhat}{\widehat{\bvec}}\) \(\newcommand{\bperp}{\bvec^\perp}\) \(\newcommand{\xhat}{\widehat{\xvec}}\) \(\newcommand{\vhat}{\widehat{\vvec}}\) \(\newcommand{\uhat}{\widehat{\uvec}}\) \(\newcommand{\what}{\widehat{\wvec}}\) \(\newcommand{\Sighat}{\widehat{\Sigma}}\) \(\newcommand{\lt}{<}\) \(\newcommand{\gt}{>}\) \(\newcommand{\amp}{&}\) \(\definecolor{fillinmathshade}{gray}{0.9}\)

    Any condition that can cause fluid electrolyte imbalances, such as cardiac, circulatory, endocrine, gastrointestinal or lung disorders, malnutrition, kidney dysfunction, or acid-base imbalance requires frequent monitoring of blood electrolytes (Ambati et al., 2023). Electrolyte evaluation is done through a blood specimen using lithium heparin tubes. Common laboratory ranges will vary slightly depending on location and facility protocols. Table B1 lists common laboratory ranges and clinical manifestations for each electrolyte.

    Electrolyte Normal Range Mild to Moderate Range Complications
    Sodium 135–145 mmol/L Hyponatremia: 125–135 mmol/L
    Hypernatremia: 145–160 mmol/L
    May lead to neurological consequences such as seizures
    Potassium 3.6–5.5 mmol/L Mild hypokalemia: < 3.6 mmol/L
    Moderate hypokalemia: < 2.5 mmol/L
    Mild hyperkalemia: 5–5.5 mmol/L
    Moderate hyperkalemia: 5.5–6.5 mmol/L
    May lead to cardiac arrhythmias, fatigue, lethargy, and muscle weakness
    Calcium 8.8–10.7 mg/dL Hypocalcemia: < 8.8 mg/dL
    Hypercalcemia: > 10.7–11.5 mg/dL
    May lead to cardiac arrhythmias, fatigue, lethargy, and muscle weakness
    Bicarbonate 23–30 mmol/L Acidosis: < 23 mmol/L
    Alkalosis: > 30 mmol/L
    Increases or decreases depending on acid-base status either respiratory or metabolic
    Acidosis: may inhibit O2 transport at the cellular level
    Alkalosis: may cause tetany and paresthesia
    Magnesium 1.46–2.68 mg/dL Hypomagnesemia: < 1.46 mg/dL
    Hypermagnesemia: > 2.68 mg/dL
    May lead to neurological consequences such as seizures, imbalances, fatigue, lethargy, and muscle weakness
    Chloride 95–105 mEq/L Hypochloremia: < 95 mEq/L
    Hyperchloremia: > 105 mEq/L
    Hypochloremia may lead to fatigue and weakness
    Hyperchloremia may lead to high blood pressure, changes in fluid secretion, headache, metabolic acidosis, muscle cramps, arrythmias, and confusion
    Phosphorus 3.4–4.5 mg/dL Hypophosphatemia: < 2.5 mg/dL
    Hyperphosphatemia: > 4.5 mg/dL
    May lead to bone and muscle disorders and increase risk of cardiovascular and neurological disorders
    Table B1 Electrolyte Imbalances (Hoppe et al., 2018)

    Significant variation can occur depending on the cause of each electrolyte imbalance. Many electrolytes are interdependent of one another, meaning that if one is abnormal, it can elicit a chain reaction causing others to become abnormal (Kraut & Madias, 2017). The delicate balance of fluid and electrolytes within the body to maintain homeostasis needs constant and comprehensive evaluation. Table B2 lists the most common causes.

    Electrolyte Cause
    Sodium Hyponatremia: adrenal insufficiency, cirrhosis, chronic hyperglycemia, heart failure, low dietary sodium intake, polydipsia, severe dyslipidemia, and syndrome of inappropriate antidiuretic hormone secretion (SIADH)
    Hypernatremia: hypertonic IV administration, osmotic diuresis, or unreplaced fluid loss via the skin or gastrointestinal tract
    Potassium Hypokalemia: aldosteronism or administration of loop diuretics
    Hyperkalemia: acute kidney injury, administration of beta blockers, insulin deficiency, metabolic acidosis
    Calcium Hypercalcemia: malignancy, hyperparathyroidism, malignancies, or tuberculosis
    Hypocalcemia: pancreatitis, parathyroid dysfunction, hypomagnesemia, or sepsis
    Bicarbonate Increase: metabolic alkalosis or respiratory acidosis
    Decrease: metabolic acidosis or respiratory alkalosis
    Magnesium Hypermagnesemia: ingestion of high amounts of oral magnesium, such as over-the-counter antacids, and renal failure
    Hypomagnesemia: alcohol use disorder, diuretic administration, or fluid loss such as from excessive vomiting and diarrhea
    Chloride Hyperchloremia: administration of excessive IV NS, diarrhea, ingestion of saltwater, and excessive amounts of salt
    Hypochloremia: excessive vomiting, diarrhea, or other gastrointestinal fluid loss
    Phosphorus Hypophosphatemia: parathyroid disorders, and vitamin D deficiency
    Hyperphosphatemia: kidney injury and parathyroid disorders
    Table B2 Common Causes of Electrolyte Imbalances (Shrimanker & Bhattarai, 2023)

    References

    Ambati, R., Kho, L. K., Prentice, D., & Thompson, A. (2023). Osmotic demyelination syndrome: novel risk factors and proposed pathophysiology. Internal Medicine Journal, 53(7), 1154–1162. doi.org/10.1111/imj.15855

    Kraut, J. A., & Madias, N. E. (2017). Adverse effects of the metabolic acidosis of chronic kidney disease. Advances in Chronic Kidney Disease, 24(5), 289–297. https://doi.org/10.1053/j.ackd.2017.06.005

    Hoppe, L. K., Muhlack, D. C., Koenig, W., Carr, P. R., Brenner, H., & Schöttker, B. (2018). Association of abnormal serum potassium levels with arrhythmias and cardiovascular mortality: A systematic review and meta-analysis of observational studies. Cardiovascular Drugs and Therapy, 32(2), 197–212. https://doi.org/10.1007/s10557-018-6783-0

    Shrimanker, I., & Bhattarai, S. Electrolytes. (2023 Jul 24). StatPearls [Internet]. www.ncbi.nlm.nih.gov/books/NBK541123/


    This page titled 39.1: Appendix B- Major Fluid and Electrolyte Imbalances was last modified on Thu, 13 Feb 2025 23:29:06 GMT and is shared under a CC BY 4.0 license and was authored, remixed, and/or curated by OpenStax.

    • Was this article helpful?